Blue Sky Asset Management’s Pediatrix Medical MD Stock Holding History

Blue Sky Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,266	Closed	-$116K	–	32
2019 Q1	$116K	Sell	4,266 -5,679	-57%	-$190K	0.26%	52
2018 Q4	$328K	Buy	+9,945	New	+$400K	0.53%	25

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Blue Sky Asset Management's MD Position: Q2 2019 in Review

Blue Sky Asset Management sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 4,266 shares — an estimated $116K sold.

Blue Sky Asset Management first reported a position in MD in Q4 2018 and held it in 2 quarters. The position peaked at $328K in Q4 2018. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

Blue Sky Asset Management reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
Blue Sky Asset Management sold 4,266 Pediatrix Medical shares in Q2 2019, an estimated $116K.
Blue Sky Asset Management first reported a position in Pediatrix Medical in Q4 2018 and held it in 2 quarters.
Blue Sky Asset Management's Pediatrix Medical position peaked at $328K in Q4 2018.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Blue Sky Asset Management's 13F filing for Q2 2019.